Activity from announced rounds
Nextech Invest is the investment manager whose official portfolio includes Khartis, Parabilis and Circle Pharma.
Circle develops macrocycle medicines. Khartis develops oral treatments for immune and chronic diseases, while Parabilis targets difficult cancer proteins. These are distinct drug-development programs within the recorded company history.
Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.
Develops oral small molecule therapies for immunological and chronic diseases
Develops medicines targeting historically undruggable protein targets in cancer